UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

1p36 tumor suppression--a matter of dosage?

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (23), p.6079-6088

2012

Volltextzugriff (PDF)

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma

British journal of cancer, 2022-11, Vol.127 (11), p.2006-2015

2022

Volltextzugriff (PDF)

Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma

Cellular and molecular life sciences : CMLS, 2019-06, Vol.76 (11), p.2231-2243

2019

Volltextzugriff (PDF)

Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas

Cancer research (Chicago, Ill.), 2016-09, Vol.76 (18), p.5523-5537

2016

Volltextzugriff (PDF)

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation

Cancers, 2020-11, Vol.12 (11), p.3465

2020

Volltextzugriff (PDF)

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma

Nature genetics, 2021-05, Vol.53 (5), p.683-693

2021

Volltextzugriff (PDF)

Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma

Molecular oncology, 2016-02, Vol.10 (2), p.344-359

2016

Volltextzugriff (PDF)

Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome

Nature genetics, 2023-04, Vol.55 (4), p.619-630

2023

Volltextzugriff (PDF)

Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Nature (London), 2015-10, Vol.526 (7575), p.700-704

2015

Volltextzugriff (PDF)

Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma

Cancer research (Chicago, Ill.), 2010-05, Vol.70 (9), p.3791-3802

2010

Volltextzugriff (PDF)

FOXR2 Stabilizes MYCN Protein and Identifies Non– MYCN -Amplified Neuroblastoma Patients With Unfavorable Outcome

Journal of clinical oncology, 2021-10, Vol.39 (29), p.3217-3228

2021

Volltextzugriff (PDF)

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas

Genome biology, 2008-01, Vol.9 (10), p.R150-R150

2008

Volltextzugriff (PDF)

High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status

Clinical cancer research, 2007-08, Vol.13 (16), p.4695-4703

2007

Volltextzugriff (PDF)

Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients

Clinical cancer research, 2006-01, Vol.12 (1), p.131-138

2006

Volltextzugriff (PDF)

Super enhancers define regulatory subtypes and cell identity in neuroblastoma

Nature cancer, 2021-01, Vol.2 (1), p.114

2021

Volltextzugriff (PDF)

CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8), p.3142-3151

2011

Volltextzugriff (PDF)

The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells

Oncoimmunology, 2016-07, Vol.5 (7), p.e1116674-e1116674

2016

Volltextzugriff (PDF)

Wnt signalling is a bi-directional vulnerability of cancer cells

Oncotarget, 2016-09, Vol.7 (37), p.60310-60331

2016

Volltextzugriff (PDF)

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma

Oncotarget, 2015-12, Vol.6 (41), p.43182-43201

2015

Volltextzugriff (PDF)

p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas

Human molecular genetics, 2014-12, Vol.23 (25), p.6826-6837

2014

Volltextzugriff (PDF)

Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias

International journal of cancer, 2007-01, Vol.120 (2), p.297-302

2007

Volltextzugriff (PDF)

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

Life science alliance, 2021-05, Vol.4 (5), p.e201900332

2021

Volltextzugriff (PDF)

Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma

Cancer letters, 2009-11, Vol.285 (1), p.99-107

2009

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(39)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(29)
Humans
(26)
Oncology
(21)
Neuroblastoma - Genetics
(20)
Neuroblastoma
(17)
Tumors
(16)
Cell Line, Tumor
(15)
Neuroblastoma - Pathology
(15)
Neuroblastoma - Metabolism
(9)
Gene Expression Regulation, Neoplastic
(8)
Infant
(7)
Mutation
(7)
N-Myc Proto-Oncogene Protein
(7)
Animals
(6)
Biological And Medical Sciences
(6)
Cancer
(6)
Child
(6)
Genetics & Heredity
(6)
Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(9)
Cancer Letters
(3)
Nature Genetics
(3)
Clinical Cancer Research
(2)
Nature Cancer
(2)
Oncotarget
(2)
Brain, Behavior, & Immunity. Health
(1)
British Journal Of Cancer
(1)
Cancers
(1)
Cellular And Molecular Life Sciences
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1p36 tumor suppression--a matter of dosage?

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma

Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma

Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas

ALK positively regulates MYCN activity through repression of HBP1 expression

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma

Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma

Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome

Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma

FOXR2 Stabilizes MYCN Protein and Identifies Non– MYCN -Amplified Neuroblastoma Patients With Unfavorable Outcome

MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas

High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status

Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients

Super enhancers define regulatory subtypes and cell identity in neuroblastoma

CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells

The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells

Wnt signalling is a bi-directional vulnerability of cancer cells

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma

p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas

Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma

Suchergebnisse filtern